Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 301 AL 315

Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process

De Strooper B.

Physiol Rev. 2010 Apr;90(2):465-94. doi: 10.1152/physrev.00023.2009.

Oxidative stress in Alzheimer disease: a possibility for prevention

Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA.

Neuropharmacology. 2010 Sep-Oct;59(4-5):290-4. doi: 10.1016/j.neuropharm.2010.04.005. Epub 2010 Apr 13.

Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies

Taupin P.

Drug Discov Today. 2010 Dec;15(23-24):983-4. doi: 10.1016/j.drudis.2010.04.001. Epub 2010 Apr 13.

Omega-3 fatty acids: potential role in the management of early Alzheimer's disease

Jicha GA, Markesbery WR.

Clin Interv Aging. 2010 Apr 7;5:45-61. doi: 10.2147/cia.s5231.

L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline

McCaddon A, Hudson PR.

CNS Spectr. 2010 Jan;15(1 Suppl 1):2-5; discussion 6. doi: 10.1017/s1092852900027589.

Anticholinesterase duration in the Australian veteran population

Gadzhanova S, Roughead L, Mackson J.

Aust N Z J Psychiatry. 2010 May;44(5):469-74. doi: 10.3109/00048670903555104.

ACAT inhibition and amyloid beta reduction

Bhattacharyya R, Kovacs DM.

Biochim Biophys Acta. 2010 Aug;1801(8):960-5. doi: 10.1016/j.bbalip.2010.04.003. Epub 2010 Apr 14.

Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models

Choi JK, Carreras I, Dedeoglu A, Jenkins BG.

Neuropharmacology. 2010 Sep-Oct;59(4-5):353-7. doi: 10.1016/j.neuropharm.2010.03.011. Epub 2010 Apr 22.

Phospholipase D in brain function and Alzheimer's disease

Oliveira TG, Di Paolo G.

Biochim Biophys Acta. 2010 Aug;1801(8):799-805. doi: 10.1016/j.bbalip.2010.04.004. Epub 2010 Apr 23.

Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape

Miller Y, Ma B, Nussinov R.

Chem Rev. 2010 Aug 11;110(8):4820-38. doi: 10.1021/cr900377t.

Alzheimer's disease drug discovery: Abeta and beyond

Shineman DW, Fillit HM.

Curr Alzheimer Res. 2010 May;7(3):188-9. doi: 10.2174/156720510791050939.

REVIEW: Curcumin and Alzheimer's disease

Hamaguchi T, Ono K, Yamada M.

CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x.

Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease

Yeh SB, Yeh PY, Schenck CH.

J Clin Sleep Med. 2010 Apr 15;6(2):192-5.

Molecular mechanisms of neurodegeneration in Alzheimer's disease

Crews L, Masliah E.

Hum Mol Genet. 2010 Apr 15;19(R1):R12-20. doi: 10.1093/hmg/ddq160. Epub 2010 Apr 22.

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline

Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U.

J Alzheimers Dis. 2010;20 Suppl 2(Suppl 2):S499-512. doi: 10.3233/JAD-2010-100504.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias